EML heads into its May 12 earnings release with a notable contrast: insiders and activist investors have been buying steadily since early March, while borrowing costs have climbed sharply in recent weeks and short interest is up 24% over the past month.
The ownership story is the clearest signal right now. Barington Capital — the activist investor with board representation — added shares on both March 6 and March 9, with James Mitarotonda personally purchasing over 7,400 shares in the two transactions alone. Independent Director Frederick DiSanto has made multiple open-market purchases since December, most recently in early March. Net insider buying over the 90-day window totals around 10,500 shares worth roughly $197,000. That's not transformative in dollar terms for a micro-cap trading near $22, but the consistency and activist backing make it hard to ignore. Barington now holds just over 10.7% of shares outstanding, with GAMCO Investors sitting atop the register at 11.3%.
The positioning picture is more mixed than the insider signal suggests. Short interest has climbed to 2.8% of the free float — modest in absolute terms, but up roughly 24% over the past month as shorts rebuilt a position that had sat well below 170,000 shares through mid-March. Days to cover run at an elevated 13.7 (FINRA-reported), and the ORTEX short score has crept to 49.9, its highest reading in this recent window. Borrow costs have also tightened materially: the cost to borrow has risen 54% over the past month and is up 28% on the week to 1.31% annually. That's still a cheap borrow in absolute terms, but the direction of travel is worth noting. Availability remains relatively loose — the lending pool isn't squeezed — but the combined move in shorts and borrowing costs signals growing conviction from the short side heading into the print.
The broader setup for the stock has improved over the past month. The price has gained 12.6%, rising to $22.25, with a further 1.8% added this week. That recovery follows full-year 2025 results reported in early March, when The Eastern Company posted net income of $7.1 million versus a net loss the prior year — a meaningful swing from red to black, even as sales slipped to $249 million from $273 million. The RSI14 sits at 60.7, gently elevated but not overbought. The ORTEX dividend score ranks at the 72nd percentile, though the most recent dividend data in the system is stale — the company has not paid a dividend since at least mid-2022 based on available history.
The Q1 2026 report is now confirmed for after-market close on May 12, with a call the following morning on May 13. The last earnings reaction in early March produced a modest initial decline of roughly 3.7%, but the stock recovered to post an 8.3% gain over the following week. The prior print in March 2026 — which included the full-year 2025 numbers — generated a 7.5% one-day gain. Those swings are wide for a $134 million market-cap name with thin liquidity.
What to watch into the May 12 release: whether the short rebuild continues to accelerate or plateaus, whether Barington or DiSanto add more shares ahead of the print, and how the company characterises tariff exposure in its industrial components business — that narrative has moved the sector broadly in recent weeks and is likely to frame how the market reads any beat or miss.
See the live data behind this article on ORTEX.
Open EML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
